Publications by authors named "Engin Hendem"

Claim this Profile
C
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma.
Hasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, Nargız Majidova, Tugay Avci, Engin Hendem

J Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Role of Thiamine Pyrophosphate Against Erlotinib-Induced Oxidative and Inflammatory Damage in Rat Optic Nerve.
Ezgi Karatas, Bulent Yavuzer, Ozlem Demir, Esra Tuba Sezgin, Engin Hendem

Biomedicines· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma.
Tarık Demir, Murat Araz, Carolyn Moloney, Engin Hendem, Mehmet Zahid Koçak

Clin Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.
Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen, Tahir Yerlikaya, Engin Hendem

Cancer Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive metastatic ependymoma with long-term progression-free survival with capecitabine plus temozolomide combination chemotherapy: A case report.
Engin Hendem, Mustafa Korkmaz, Murat Araz, Melek K Eryılmaz, Dilek Çağlayan

J Cancer Res Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.
Mustafa Korkmaz, Melek Karakurt Eryılmaz, Mehmet Zahid Koçak, Muhammed Muhiddin Er, Engin Hendem

Eur J Clin Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Çağlar Ünal, Abdulmunir Azizy, Senem Karabulut, Didem Taştekin, Arif Akyıldız, Engin Hendem

Oncologist· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.
Muzaffer Uğraklı, Mehmet Zahid Koçak, Gülhan Dinç, Tuğrul Burak Genç, Melek Çağlayan, Engin Hendem

J Cancer Res Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib-induced hepatotoxicity.
Muhammed Muhiddin Er, Murat Araz, Engin Hendem, Melek Karakurt Eryılmaz, Mehmet Artaç

J Oncol Pharm Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.
Murat Bardakci, Derya Demirtas Esmer, Emre Hafizoglu, Sendag Yaslikaya, Tugrul Burak Genc, Engin Hendem

Oncology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?
Mehmet Zahid Kocak, Muhiddin Er, Muzaffer Ugrakli, Engin Hendem, Murat Araz

Eur J Clin Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?
Mustafa Korkmaz, Melek K Eryılmaz, Mehmet Z Koçak, Muhammed M Er, Engin Hendem

J Cancer Res Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is pancreatic giant cell tumor resistant to standard chemotherapy?
Dilek Çağlayan, Melek Karakurt Eryilmaz, Mustafa Korkmaz, Mustafa Karaağaç, Engin Hendem

Anticancer Drugs· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy.
Engin Hendem, Mustafa Korkmaz, Muzaffer Uğraklı, Melek Karakurt Eryılmaz, Mustafa Karaağaç

J Oncol Pharm Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer.
Mustafa Korkmaz, Engin Hendem, Melek Karakurt Eryılmaz, Aykut Demirkıran, Mustafa Karaağaç

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis